Nektar Therapeutics · NASDAQ:NKTR
Vanguard Capital Management LLC reported a 5.17% stake in Nektar Therapeutics (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Capital Management LLC reported a 5.17% stake in Nektar Therapeutics, 1,747,653 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).
- Stake
- 5.17%
- Shares
- 1,747,653
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.17% | 1,747,653 |